BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 35794636)

  • 1. Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.
    Koss DJ; Erskine D; Porter A; Palmoski P; Menon H; Todd OGJ; Leite M; Attems J; Outeiro TF
    Acta Neuropathol Commun; 2022 Jul; 10(1):98. PubMed ID: 35794636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered TFEB subcellular localization in nigral neurons of subjects with incidental, sporadic and GBA-related Lewy body diseases.
    Moors TE; Morella ML; Bertran-Cobo C; Geut H; Udayar V; Timmermans-Huisman E; Ingrassia AMT; Brevé JJP; Bol JGJM; Bonifati V; Jagasia R; van de Berg WDJ
    Acta Neuropathol; 2024 Apr; 147(1):67. PubMed ID: 38581586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders.
    Altay MF; Liu AKL; Holton JL; Parkkinen L; Lashuel HA
    Acta Neuropathol Commun; 2022 Nov; 10(1):163. PubMed ID: 36371251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy.
    Moors TE; Maat CA; Niedieker D; Mona D; Petersen D; Timmermans-Huisman E; Kole J; El-Mashtoly SF; Spycher L; Zago W; Barbour R; Mundigl O; Kaluza K; Huber S; Hug MN; Kremer T; Ritter M; Dziadek S; Geurts JJG; Gerwert K; Britschgi M; van de Berg WDJ
    Acta Neuropathol; 2021 Sep; 142(3):423-448. PubMed ID: 34115198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies.
    Moors TE; Mona D; Luehe S; Duran-Pacheco G; Spycher L; Mundigl O; Kaluza K; Huber S; Hug MN; Kremer T; Ritter M; Dziadek S; Dernick G; van de Berg WDJ; Britschgi M
    Acta Neuropathol Commun; 2022 Jun; 10(1):82. PubMed ID: 35659116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies.
    Koss DJ; Bondarevaite O; Adams S; Leite M; Giorgini F; Attems J; Outeiro TF
    Brain Pathol; 2021 Jan; 31(1):120-132. PubMed ID: 32762091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.
    Landeck N; Hall H; Ardah MT; Majbour NK; El-Agnaf OM; Halliday G; Kirik D
    Mol Neurodegener; 2016 Aug; 11(1):61. PubMed ID: 27549140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
    Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia.
    van der Gaag BL; Deshayes NAC; Breve JJP; Bol JGJM; Jonker AJ; Hoozemans JJM; Courade JP; van de Berg WDJ
    Acta Neuropathol; 2024 Jan; 147(1):14. PubMed ID: 38198008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay.
    Arlinghaus R; Iba M; Masliah E; Cookson MR; Landeck N
    J Parkinsons Dis; 2023; 13(2):255-270. PubMed ID: 36847016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.
    Lashuel HA
    Neurobiol Dis; 2020 Jul; 141():104876. PubMed ID: 32339655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
    Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
    Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
    Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
    Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lewy Bodies and the Mechanisms of Neuronal Cell Death in Parkinson's Disease and Dementia with Lewy Bodies.
    Power JH; Barnes OL; Chegini F
    Brain Pathol; 2017 Jan; 27(1):3-12. PubMed ID: 26667592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregated Alpha-Synuclein Inclusions within the Nucleus Predict Impending Neuronal Cell Death in a Mouse Model of Parkinsonism.
    Weston LJ; Bowman AM; Osterberg VR; Meshul CK; Woltjer RL; Unni VK
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.
    Seidel K; Mahlke J; Siswanto S; Krüger R; Heinsen H; Auburger G; Bouzrou M; Grinberg LT; Wicht H; Korf HW; den Dunnen W; Rüb U
    Brain Pathol; 2015 Mar; 25(2):121-35. PubMed ID: 24995389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
    Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
    Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD.
    Francis PT
    J Neurol; 2009 Aug; 256 Suppl 3():280-5. PubMed ID: 19711117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.